Skip to content

Effects of Neuromuscular Electrical Stimulation in Patients With Congestive Heart Failure

Effects of Neuromuscular Electrical Stimulation in Patients With Congestive Heart Failure

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02313714
Enrollment
15
Registered
2014-12-10
Start date
2012-09-30
Completion date
2015-12-31
Last updated
2014-12-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Heart Failure

Keywords

heart failure, heart transplant, electrical stimulation

Brief summary

This study intends to treat patient with congestive heart failure that are maximized their pharmacological treatment and at heart transplant wait list. All patients in the treatment arm will receive electric muscular stimulation with a Russian current protocol twice a week for 7 weeks. The outcome will be assessed by the improvement in quality of life and functional capacity.

Detailed description

The neuromuscular electrical stimulation (NMES) has been used as adjuvant treatment in patients with end-stage congestive heart failure. Those patients are limited to perform conventional physical activity and adherence to any every day protocols frequency. The aim of this study was evaluated the effect on functional status and quality of life after NMES treatment using Russian stimulation wave solely twice a week during five weeks period in patients waiting for a heart transplant. Inclusion criteria: Age between 30 to 80 years old Congestive heart failure in NYHA class III or IV Ejection fraction lower than 35% Stable clinical status Full pharmacologic treatment Exclusion criteria: Unstable angina Ventricular arrhythmia intermittent lameness Inferior limb amputation Protocol Design: Patients at waiting list for heart transplant will be invited to participate on protocol of NMES using Russian stimulation wave (2.5 kHz, burst at 50Hz, on/off: 3/9 sec), named NMES group or sham stimulation, named control group. The NMES will be applied for 50 minutes, twice a week on both quadriceps femoral muscles during 7 weeks. The patients will be evaluated every week for distance walked during six minutes walk test (6MWT), heart rate variability, and functional status according to New York Heart Association. All patients were evaluated at the beginning and after completion of the protocol for quality of life with Minnesota Living with Heart Failure Questionnaire (LHFQ).

Interventions

DEVICEstimulation wave (2.5 kHz, burst at 50Hz, on/off: 3/9 sec),

All patients in the treatment arm will receive electric muscular stimulation with a Russian current protocol twice a week for 7 weeks.

DEVICESham

very low electric muscular stimulation

Sponsors

University of Campinas, Brazil
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
18 Years to 90 Years
Healthy volunteers
No

Inclusion criteria

* patients on waiting list for heart transplant

Exclusion criteria

* patients that won't accept to participate in the protocol

Design outcomes

Primary

MeasureTime frame
Improvement on distance walked in the six minute walk testafter 7 weeks of first inttervention

Secondary

MeasureTime frame
Improvement on quality of life7 weeks after first intervention

Countries

Brazil

Contacts

Primary ContactMaria Carolina Sacilotto, MsC
carolsaci@yahoo.com.br+55 19 989464664
Backup ContactOrlando Petrucci, MD, PhD
orlando@fcm.unicamp.br+55 19 997253335

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026